Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.100 | None | 1.000 | 38 | 0 | 1987 | 2016 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 1995 | 2017 | |||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 1987 | 2012 | |||||||||
|
T cell receptor gamma locus | 0.631 | 0.538 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1987 | 2014 | |||||||||
|
H3 histone pseudogene 9 | 0.505 | 0.731 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1995 | 2017 | |||||||||
|
TCR gamma alternate reading frame protein | 0.638 | 0.500 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1994 | 2014 | |||||||||
|
T cell receptor gamma constant 1 | 0.663 | 0.385 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1994 | 2014 | |||||||||
|
suppression of anchorage independence 1 | 0.560 | 0.615 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1994 | 1999 | |||||||||
|
caspase 8 associated protein 2 | 0.659 | 0.500 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2006 | 2018 | |||||||||
|
CXADR pseudogene 1 | 0.463 | 0.846 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2018 | 2019 | |||||||||
|
Hyperreflexia | 0.695 | 0.192 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 1993 | 1997 | |||||||||
|
hypertrichosis 2 (generalized, congenital) | 0.392 | 0.808 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2016 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.050 | None | 0.800 | 5 | 1 | 2010 | 2019 | |||||||||
|
microRNA 196b | 0.561 | 0.731 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2009 | 2017 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1995 | 2012 | |||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1993 | 2019 | |||||||||
|
T cell receptor delta joining 1 | 0.736 | 0.269 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2010 | |||||||||
|
T cell receptor delta diversity 3 | 0.736 | 0.269 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2010 | |||||||||
|
T cell receptor delta constant | 0.729 | 0.269 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2010 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1991 | 2000 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1991 | 2000 | |||||||||
|
microRNA 100 | 0.521 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2012 | 2019 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2019 | 2020 | |||||||||
|
microRNA 210 | 0.460 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2019 | |||||||||
|
microRNA 223 | 0.433 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2015 |